Nordic Labs tirzepatide: sorting fact from fiction for UK patients

The misconception: that Nordic Labs tirzepatide is a legitimate UK treatment option

The biggest misunderstanding driving searches for this term is straightforward: people assume that because tirzepatide is the active ingredient in Mounjaro, any product containing that molecule is equally valid. It isn't. In the UK, medicines regulation doesn't work by ingredient alone — it works by product, manufacturer, manufacturing site, quality standard and supply chain. A tirzepatide product from an unlicensed source has not been assessed by the MHRA for safety, efficacy or quality. You have no way of knowing what is actually in the pen, what dose it delivers, or whether the storage and handling from production to your door has been anything close to pharmaceutical standard.

Nordic Labs is not a brand name recognised within the MHRA's licensed medicines register. Products bearing this name, or similar informal 'research chemical' branding, are not approved for human use under UK law. The MHRA has been clear on this throughout 2024 and 2025: tirzepatide is a prescription-only medicine, and obtaining or supplying it without proper authorisation is illegal. In October 2025, enforcement officers raided a UK manufacturing site in Northampton that was producing counterfeit tirzepatide pens, evidence that the market for unlicensed product is not theoretical. You can read more about the tirzepatide landscape in the UK and how licensed supply works.

If you've come across this product name through a forum recommendation or social media post, that context matters. Well-meaning advice from people who believe they've had positive results does not make unlicensed supply safe or legal, and counterfeit or substandard products have caused real harm to real people.

What the licensed alternative actually looks like, and why the difference matters

Mounjaro is the only tirzepatide product licensed by the MHRA for use in the UK, available in six strengths: 2.5, 5, 7.5, 10, 12.5 and 15 mg. It comes as a pre-filled KwikPen containing four weekly doses. Treatment begins at 2.5 mg, a dose designed to let your body adjust before moving upward, each titration step is a clinical decision made by the prescriber based on how you're tolerating treatment and how your weight is responding.

The pen needs to be stored in the fridge at 2–8°C, many people keep it in the fridge door next to everyday items, which is perfectly fine as long as the temperature stays consistent. Exact guidance on taking it briefly to room temperature before injection is in the Patient Information Leaflet; your prescriber will walk you through it.

In the SURMOUNT-1 trial, involving 2,539 adults with obesity, participants using the highest dose of tirzepatide achieved an average body-weight reduction of around 20–21% over 72 weeks. That evidence underpins NICE's recommendation of tirzepatide in Technology Appraisal TA1026, published in December 2024 and updated in September 2025. Private prescribing through a regulated pharmacy gives people who don't meet NHS criteria, or who prefer not to wait, a lawful route to access it, provided they go through proper clinical assessment. Our tirzepatide prescribing process page covers what that involves in practice.

How to tell whether a tirzepatide source is legitimate

There are a few straightforward checks that apply to any online source of prescription medicines. First, check the GPhC register. Every pharmacy legally dispensing prescription medicines in the UK must be registered with the General Pharmaceutical Council, you can verify any pharmacy at the GPhC pharmacy register within seconds. If a seller of tirzepatide cannot be found there, it is not a licensed pharmacy and should not be supplying prescription medicines to you.

Second, consider whether a prescriber was actually involved. A genuine prescription for tirzepatide requires a registered prescriber to review your medical history, your current BMI and any relevant conditions. If a website offers tirzepatide with no clinical consultation, or asks you to tick a box and pay, that is not a prescription in any meaningful sense. The MHRA's guidance on reporting suspect sellers through the Yellow Card scheme is the right route if you encounter a site behaving this way.

Third, be cautious about pricing. Tirzepatide supplied through the licensed UK supply chain carries a real cost, and if you want to understand exactly who manufactures the treatment you're taking, our page on Novo Nordisk and Mounjaro explains the manufacturing and licensing background in detail. Prices well below that range are a signal that something in the supply chain is not right. For a clear picture of what private treatment costs and what it includes, the Mounjaro cost page sets out the relevant context.

Getting access to licensed tirzepatide through a regulated route

If this page has been useful, the practical next step is simple. A free consultation with a GPhC-registered prescriber is the beginning of any legitimate tirzepatide journey. At nume, a real clinician reads your consultation the same day, not a decision tree or automated system. If tirzepatide is clinically appropriate, your prescription is issued and your Mounjaro pen is dispatched the same working day for free next-working-day delivery by DPD, in plain packaging.

You can also read more about how licensed Mounjaro treatment compares to the broader landscape of weight-loss treatment options we offer, or visit our about page to understand how our pharmacy is registered and regulated. If you have specific questions before starting, our FAQs cover the queries our prescribers hear most often.

Speak to our prescribers through a free consultation at our treatment page, it's the straightforward, lawful way to find out whether Mounjaro is right for you.